During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. | During a busy ...
History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up ...
After Adstiladrin's FDA approval in late 2022, Ferring Pharmaceuticals finally established unfettered supply of the bladder ...
Immunology is AbbVie’s world, everyone else just lives in it. | Immunology is AbbVie’s world, everyone else just lives in it. That is the takeaway from ZoomRx’s analysis of the perceptions of ...
Lights, camera, Alexion! Fresh off earning FDA approval for its drug Ultomiris to treat certain adults with neuromyelitis ...
AbbVie's star immunology drug Rinvoq picked up its seventh FDA approval< | AbbVie's Rinvoq has racked up seven FDA approvals ...
Thomas Lingelbach, CEO of French vaccine specialist Valneva, said that the company is focused on launching its newly approved ...
The ongoing shortage of Eli Lilly’s popular diabetes med Mounjaro doesn’t look to be letting up anytime soon, with the FDA ...
Two weeks after gaining a hard-earned FDA label expansion for its long-established antipsychotic drug Fanapt (iloperidone), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results